Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma

Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma

Background. GPNMB is a newly discovered tumour-promoting factor that may promote tumour cell progression by activating the PI3K/AKT pathway by EGFR. However, there are insufficient studies about GPNMB in ESCC. This study investigated the relationship between GPNMB and EGFR/PI3K pathway genes in ESCC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bo Wang, Mengyan Li, Anna Su, Yongmei Gao, Yan Shi, Chao Li, Wenying Liu, Liping Su, Wan Li, Yuqing Ma
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Analytical Cellular Pathology
Online Access:	http://dx.doi.org/10.1155/2022/9303081
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunoexpression of P16 and Ki 67 in oral squamous cell carcinoma: Association with clinicopathological parameters.
by: Shadan Mohamad Omer, et al.
Published: (2020-12-01)

Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
by: Wang Wenhui, et al.
Published: (2024-12-01)

Prognostic relevance of Ki-67 and P16/INK4a markers in histological diagnosis of cervical dysplasia
by: T. A. Dimitriadi, et al.
Published: (2020-03-01)

Multi-institutional evaluation comparing guidance from International Ki67 Working Group vs National Health Commission of China on immunohistochemistry-based Ki67 assessment alongside the Quantitative Dot Blot method
by: Yin Wang, et al.
Published: (2025-01-01)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
by: Toyaja Jadhav, et al.
Published: (2023-07-01)

Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
by: Clarice F. E. M. Osório, et al.
Published: (2025-01-01)

Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
by: Sumaira Siddiqui
Published: (2024-04-01)

The Impact of p53 and Ki67 Expression in Endometrial Cancer and its Effect on Survival
by: Zekiye Sahin, et al.
Published: (2022-03-01)

Ki-67 and CDK1 control the dynamic association of nuclear lipids with mitotic chromosomes
by: Hsiao-Tang Hu, et al.
Published: (2025-01-01)

MSC-sEVs exacerbate senescence by transferring bisecting GlcNAcylated GPNMB
by: Yihan Ma, et al.
Published: (2025-01-01)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
by: Jan P. A. Baak, et al.
Published: (2005-01-01)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
by: Rosella Silvestrini
Published: (2005-01-01)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
by: Arnold-Jan Kruse, et al.
Published: (2004-01-01)

Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01)

Potential value of novel multiparametric MRI radiomics for preoperative prediction of microsatellite instability and Ki-67 expression in endometrial cancer
by: Zhichao Wang, et al.
Published: (2025-01-01)

Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers
by: José M. Lopes, et al.
Published: (1998-01-01)

Vitamin D Receptor, Retinoid X Receptor, Ki-67, Survivin, and Ezrin Expression in Canine Osteosarcoma
by: John Davies, et al.
Published: (2012-01-01)

H. Wendl Leaf Metabolites Potentiate the Radiosensitivity of Hepatocellular Carcinoma Through Ki67 and PARP Inhibition
by: Nabil M. Selim PhD, et al.
Published: (2025-01-01)

A multi-modal deep learning model for prediction of Ki-67 for meningiomas using pretreatment MR images
by: Chaoyue Chen, et al.
Published: (2025-01-01)

Study of morphology with assessment of expression of proliferation marker Ki67 antigen and P53 protein in lesions of gall bladder
by: Ojasvi Ramesh, et al.
Published: (2024-04-01)

Comparison of the Manual, Semiautomatic, and Automatic Selection and Leveling of Hot Spots in Whole Slide Images for Ki-67 Quantification in Meningiomas
by: Zaneta Swiderska, et al.
Published: (2015-01-01)

Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
by: Jie Hu, et al.
Published: (2024-09-01)

Inmunolocalización de citoqueratina 14, 19 y Ki-67 en el epitelio de pacientes con agrandamiento gingival
by: Víctor Simancas-Escorcia, et al.
Published: (2023-01-01)

Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
by: Vandana Puri, et al.
Published: (2011-01-01)

Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer
by: Liying Zhang, et al.
Published: (2023-01-01)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
by: Jian‐Hua Wang, et al.
Published: (2019-03-01)

Prognostic value of FCER1G expression and M2 macrophage infiltration in esophageal squamous cell carcinoma
by: Wei Peng, et al.
Published: (2025-02-01)

Prognostic significance of lymph node ratio in esophageal squamous cell carcinoma: insights from the South Asian population
by: Sajida Qureshi, et al.
Published: (2025-01-01)

The Role of EGFR/PI3K/Akt/cyclinD1 Signaling Pathway in Acquired Middle Ear Cholesteatoma
by: Wei Liu, et al.
Published: (2013-01-01)

EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
by: Shanmugappiriya Sivarajah, et al.
Published: (2019-01-01)

Endoscopic Mucosal Resection of Esophageal Squamous Papillomatosis
by: Edward Kim, et al.
Published: (2012-01-01)

Crotonylation-Related Prognostic Model of Esophageal Squamous Cell Carcinoma Based on Transcriptome Analysis and Single-Cell Sequencing Analysis
by: Lin RY, et al.
Published: (2025-01-01)

Predicting Outcomes in Esophageal Squamous Cell Carcinoma Using scRNA‐Seq and Bulk RNA‐Seq: A Model Development and Validation Study
by: Jiaqi Zhang, et al.
Published: (2025-01-01)

Sporoderm-Removed Spore Powder May Suppress the Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells Through PI3K/AKT/mTOR and Erk Pathway
by: Jingyan Liu Master degree, et al.
Published: (2021-11-01)

PARylation of HMGA1 desensitizes esophageal squamous cell carcinoma to olaparib
by: Xin‐Yuan Lei, et al.
Published: (2024-12-01)

High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
by: Hossein Schandiz, et al.
Published: (2025-01-01)

Squamous Cell Carcinoma of the Lung with Metastasis to the GI Tract Associated with EGFR Exon 19 Deletion
by: Glen J. Weiss, et al.
Published: (2013-01-01)

Targeted inhibition of the PTEN/PI3K/AKT pathway by YSV induces cell cycle arrest and apoptosis in oral squamous cell carcinoma
by: Lin Qiu, et al.
Published: (2025-02-01)

Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway
by: Sisi Wei, et al.
Published: (2025-01-01)

Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
by: Lanhua Wu, et al.
Published: (2025-01-01)